TEST BANK NURS 6630 MIDTERM
EXAM (2025-2026) COMPREHENSIVE
QUESTIONS AND VERIFIED
ANSWERS
Patient refusal to follow prescribed treatment. - ANS -Noncompliance
Disruption in brain chemical levels affecting mood. - ANS -Neurotransmitter Imbalance
Symptoms that add to the patient's experience. - ANS -Positive Symptoms
Increased restlessness or anxiety in schizophrenia. - ANS -Agitation
Neurotransmitter linked to mood regulation. - ANS -Serotonin
First antidepressant targeting serotonin imbalance. - ANS -Prozac
Impaired neurotransmitter functions in psychiatric illnesses. - ANS -Dysfunctioning
Neurotransmitter Systems
Process of converting genetic information into proteins. - ANS -Gene Expression
Protein that initiates gene transcription. - ANS -Transcription Factor
Changes in behavior influencing genetic expression. - ANS -Behavior Modification
,Enzyme system affecting drug metabolism. - ANS -Cytochrome P450
Amount of drug available after metabolism. - ANS -Bioavailability
Study of drug absorption, distribution, metabolism, and excretion. - ANS -Pharmacokinetics
Some Asians require reduced doses of medications. - ANS -Lower Drug Doses
Receptors that mediate cellular responses to neurotransmitters. - ANS -G-Protein Linked
Receptors
Medications that block receptor activity. - ANS -Antagonistic Traits
Medication used for treatment-resistant schizophrenia. - ANS -Clozapine (Clozaril)
Smoking can alter medication metabolism. - ANS -Smoking Impact
Mood stabilizer associated with thrombocytopenia. - ANS -Carbamazepine (Tegretol)
Medication used to treat mood disorders. - ANS -Mood Stabilizer
Antidepressant also used for chronic pain. - ANS -Amitriptyline (Elavil)
SSRI antidepressant for depression and anxiety. - ANS -Fluoxetine (Prozac)
,Low platelet count caused by medication. - ANS -Drug-Induced Thrombocytopenia
An antidepressant used for mood disorders. - ANS -Amitriptyline (Elavil)
Decreases serotonin and dopamine activity. - ANS -Inverse agonist
Medications for anxiety and panic disorders. - ANS -Benzodiazepines
Receptors that mediate rapid synaptic transmission. - ANS -Ionotropic receptors
Medication used for smoking cessation. - ANS -Varenicline (Chantix)
Drugs that partially stimulate receptors. - ANS -Partial agonists
Medications used to stabilize mood and treat seizures. - ANS -Anticonvulsants
Channels activated by neurotransmitter binding. - ANS -Ligand-gated ion channels
An SSRI used to treat panic disorder. - ANS -Sertraline
Used temporarily to manage anxiety symptoms. - ANS -Short-acting benzodiazepine
Medications that prevent mood swings in bipolar disorder. - ANS -Mood stabilizers
Antidepressants with significant food interactions. - ANS -MAO inhibitors
, An SSRI with uncommon sedation side effects. - ANS -Fluoxetine
Signs of elevated mood and hyperactivity. - ANS -Manic symptoms
Dopamine receptors targeted by antipsychotics. - ANS -D2 receptors
Involuntary movements from long-term antipsychotic use. - ANS -Tardive dyskinesia
Severe increase in blood pressure from food interactions. - ANS -Hypertensive crisis
Receptors involved in serotonin signaling. - ANS -Serotonin 3 receptors
Cholinergic receptors that respond to acetylcholine. - ANS -Nicotinic receptors
Receptors activated by the neurotransmitter acetylcholine. - ANS -Cholinergic receptors
Inhibitory receptors in the central nervous system. - ANS -Glycine receptors
Stimulates dopamine receptors to treat Parkinson's disease. - ANS -Dopamine agonist
Primary binding site for dopamine agonists. - ANS -D2 Receptors
Pathways influencing cognitive symptoms in schizophrenia. - ANS -Mesocorticol Projections
Antidepressant with rare induction of mania. - ANS -Fluoxetine
EXAM (2025-2026) COMPREHENSIVE
QUESTIONS AND VERIFIED
ANSWERS
Patient refusal to follow prescribed treatment. - ANS -Noncompliance
Disruption in brain chemical levels affecting mood. - ANS -Neurotransmitter Imbalance
Symptoms that add to the patient's experience. - ANS -Positive Symptoms
Increased restlessness or anxiety in schizophrenia. - ANS -Agitation
Neurotransmitter linked to mood regulation. - ANS -Serotonin
First antidepressant targeting serotonin imbalance. - ANS -Prozac
Impaired neurotransmitter functions in psychiatric illnesses. - ANS -Dysfunctioning
Neurotransmitter Systems
Process of converting genetic information into proteins. - ANS -Gene Expression
Protein that initiates gene transcription. - ANS -Transcription Factor
Changes in behavior influencing genetic expression. - ANS -Behavior Modification
,Enzyme system affecting drug metabolism. - ANS -Cytochrome P450
Amount of drug available after metabolism. - ANS -Bioavailability
Study of drug absorption, distribution, metabolism, and excretion. - ANS -Pharmacokinetics
Some Asians require reduced doses of medications. - ANS -Lower Drug Doses
Receptors that mediate cellular responses to neurotransmitters. - ANS -G-Protein Linked
Receptors
Medications that block receptor activity. - ANS -Antagonistic Traits
Medication used for treatment-resistant schizophrenia. - ANS -Clozapine (Clozaril)
Smoking can alter medication metabolism. - ANS -Smoking Impact
Mood stabilizer associated with thrombocytopenia. - ANS -Carbamazepine (Tegretol)
Medication used to treat mood disorders. - ANS -Mood Stabilizer
Antidepressant also used for chronic pain. - ANS -Amitriptyline (Elavil)
SSRI antidepressant for depression and anxiety. - ANS -Fluoxetine (Prozac)
,Low platelet count caused by medication. - ANS -Drug-Induced Thrombocytopenia
An antidepressant used for mood disorders. - ANS -Amitriptyline (Elavil)
Decreases serotonin and dopamine activity. - ANS -Inverse agonist
Medications for anxiety and panic disorders. - ANS -Benzodiazepines
Receptors that mediate rapid synaptic transmission. - ANS -Ionotropic receptors
Medication used for smoking cessation. - ANS -Varenicline (Chantix)
Drugs that partially stimulate receptors. - ANS -Partial agonists
Medications used to stabilize mood and treat seizures. - ANS -Anticonvulsants
Channels activated by neurotransmitter binding. - ANS -Ligand-gated ion channels
An SSRI used to treat panic disorder. - ANS -Sertraline
Used temporarily to manage anxiety symptoms. - ANS -Short-acting benzodiazepine
Medications that prevent mood swings in bipolar disorder. - ANS -Mood stabilizers
Antidepressants with significant food interactions. - ANS -MAO inhibitors
, An SSRI with uncommon sedation side effects. - ANS -Fluoxetine
Signs of elevated mood and hyperactivity. - ANS -Manic symptoms
Dopamine receptors targeted by antipsychotics. - ANS -D2 receptors
Involuntary movements from long-term antipsychotic use. - ANS -Tardive dyskinesia
Severe increase in blood pressure from food interactions. - ANS -Hypertensive crisis
Receptors involved in serotonin signaling. - ANS -Serotonin 3 receptors
Cholinergic receptors that respond to acetylcholine. - ANS -Nicotinic receptors
Receptors activated by the neurotransmitter acetylcholine. - ANS -Cholinergic receptors
Inhibitory receptors in the central nervous system. - ANS -Glycine receptors
Stimulates dopamine receptors to treat Parkinson's disease. - ANS -Dopamine agonist
Primary binding site for dopamine agonists. - ANS -D2 Receptors
Pathways influencing cognitive symptoms in schizophrenia. - ANS -Mesocorticol Projections
Antidepressant with rare induction of mania. - ANS -Fluoxetine
